Appears on
Articles20
I
10x Genomics, Cleveland Clinic Collaborate on Single-Cell, Spatial Diagnostics
0
Ion Genomics21d agoI
Illumina Launches WGS Study with European Newborn Sequencing Projects
0
Ion Genomics21d agoI
US Department of Defense Adds Novogene, WuXi AppTech, Complete Genomics to Watchlist
0
Ion Genomics21d agoI
Oxford Nanopore Expands Norwegian Collaboration on Rapid Brain Cancer Classification
0
Ion Genomics20d agoI
Protein sequencing-by-subtraction with Pumpkinseed Cofounder/CEO Jen Dionne
0
Ion Genomics19d agoI
German Brain Disease Center to Sequence 25K Genomes
0
Ion Genomics19d agoI
Natera, Germany’s Pirche Partner on Testing for Kidney Transplant Risk and Monitoring
0
Ion Genomics16d agoI
Natera MRD Test for Bladder Cancer Nabs Top-Level US Recommendation
0
Ion Genomics15d agoI
Illumina Doubles Down on Newborn Sequencing: Ion Genomics Newsletter, June 23, 2026
0
Ion Genomics15d agoI
Natera's Signatera Wins First MRD Approval in Japan for Colorectal Cancer
0
Ion Genomics14d agoI
Germany’s Merck to Buy Bio-Techne for $11.3 Billion
0
Ion Genomics13d agoI
Boehringer Ingelheim, Immunai Ink $15M Collaboration to Analyze T-cells
0
Ion Genomics13d agoI
Going "Founder Mode" on Cancer with Sid Sijbrandij and Jacob Stern
0
Ion Genomics12d agoI
Natera, Aveta Biomics to Incorporate MRD Testing into Phase 3 Cancer Trial
0
Ion Genomics9d agoI
Bioptimus to Expand AI-Based Tissue Atlas with French GI Cancer Network
0
Ion Genomics8d agoI
South Korea’s AimedBio Invests in Inocras, Partners on WGS for Cancer Trials
0
Ion Genomics7d agoI
Caris Launches MCED Test: Ion Genomics Newsletter, July 1, 2026
0
Ion Genomics7d agoI
World’s First CE-Certification for Whole-Genome Cancer Dx Software
0
Ion Genomics6d agoI
Illumina to Supply SBS Chemistry for Broad Spinout's Spatial Perturb-Seq Platform
0
Ion Genomics7h agoI
Newsletter, July 8: Illumina Tech Chosen by Spatial Perturb-Seq Spinout
0
Ion Genomics6h ago